The strongest direct evidence that selection distorts mtDNA inheritance comes from Chinnery et al., who analyzed 338 transmissions across six pathogenic mutations and found that random drift alone cannot explain the patterns: A8344G is significantly selected against (OβM mean < 0), while A3243G (n=80), T8993G (n=63), and G11778A (n=56) show significant positive selection . This mutation-specificity means selection is not uniformβit depends on the biochemical consequence of each variant, creating heterogeneous survivorship biases across mtDNA marker classes used in clonal reconstruction.
Complementary evidence from natural C. elegans populations (1,524 isolates) shows strong purifying selection on mtDNA polymorphism, with significantly lower median frequencies for nonsynonymous versus synonymous heteroplasmic variants .
Cancer studies provide mechanistic plausibility for why high-heteroplasmy cells face selection. In HEp-2 tumor cells, deliberate reduction of mtDNA copy number (mimicking respiratory dysfunction) via TFAM knockdown or ethidium bromide elevated ROS by downregulating antioxidant genes GSR and GLRX, and increased cisplatin/doxorubicin-induced apoptosis (p < 0.01) . ROS scavengers (NAC, lipoic acid) completely rescued the apoptosis, establishing a clear causal chain: respiratory dysfunction β ROS elevation β cell death.
TFAM manipulation in aging mice showed tissue-specific responses: overexpression impaired hepatic mtDNA expression while improving spleen physiology, confirming that selection against dysfunctional mtDNA is not uniform across tissues .
If selection eliminates cells carrying high heteroplasmy of OXPHOS-impairing mutations, mtDNA-based clonal reconstruction suffers a survivorship bias analogous to the classic "extinction of the unfit": clones carrying pathogenic variants at high heteroplasmy are disproportionately eliminated, causing their apparent expansion timeline to be compressed toward the present. A naive Wright-Fisher model assuming neutrality would date these clones as younger than they actually are, because the observed frequency decline reflects selection, not recent origin. Conversely, clones bearing selectively tolerated (synonymous or low-functional-impact) variants persist longer and appear falsely ancient relative to their true expansion time. The direction and magnitude of this bias depend on the tissue's OXPHOS dependency and the specific mutation's functional threshold.
Most mtDNA clonal reconstruction studies deliberately use synonymous or control-region variants as lineage markers precisely because these are expected to be neutral . The bias hypothesized here would primarily affect studies using missense or tRNA/rRNA mutations where functional consequences at high heteroplasmy are known. Furthermore, no direct study has yet quantified the temporal distortion in a real human tissue reconstructionβthis remains a formal prediction rather than a measured effect. The Chinnery data are from germline transmission, not somatic tissue dynamics, and the C. elegans evidence is from a different organism with different mtDNA maintenance biology.
The hypothesis would be weakened if: (1) longitudinal single-cell mtDNA tracking in human tissues showed no correlation between heteroplasmy level and cell survival/expansion rate for missense variants; (2) clonal age estimates from neutral synonymous variants were indistinguishable from those from pathogenic missense variants at equivalent frequencies; (3) tissues with high OXPHOS dependency (heart, brain) showed no systematic underrepresentation of high-heteroplasmy clones relative to glycolytic tissues.
Simulated projection under stated assumptions (Wright-Fisher with threshold selection at 60% heteroplasmy); not observed data. Illustrates how purifying selection accelerates apparent loss of high-heteroplasmy clones, biasing naive drift-based age estimates.
Generated scientific data; not direct experimental measurements.Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.